Towa Pharmaceutical Co., Ltd. (4553) Press Release
Notice of Changes in Officers
Earlier from Towa Pharmaceutical
- Towa Pharmaceutical: FY2025 Briefing Script and Q&A Summary of financial results meeting(581K／27P)
- Towa Pharmaceutical: FY2025 Supplementary Material of Financial Results(1.0M／46P)
- Towa Pharmaceutical: FY2025 Consolidated Financial Results for the Year Ended March 31, 2026(Based on Japanese GAAP) (224K／22P)
- Towa Pharmaceutical: FY2025(3rd quarter) Briefing Script and Q&A Summary of financial results meeting(296K／17P)